Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.255 USD | -2.71% | +6.84% | -29.78% |
05-10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
05-10 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.78% | 94.58M | |
+64.31% | 62.59B | |
-1.29% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.40% | 26.21B | |
-21.87% | 19.09B | |
+4.98% | 13.08B | |
+25.29% | 12.26B | |
+28.12% | 12.05B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $14.2M, vs. Street Est of $5.7M